BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kokona D, Mastrodimou N, Pediaditakis I, Charalampopoulos I, Schmid HA, Thermos K. Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies. Exp Eye Res 2012;103:90-8. [PMID: 22960304 DOI: 10.1016/j.exer.2012.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Tian W, Wang S, Wei W, Wu D, Wang H, Wang L, Yang R, Ji A, Li Y. Anti-inflammatory and retinal protective effects of capsaicin on ischaemia-induced injuries through the release of endogenous somatostatin. Clin Exp Pharmacol Physiol 2017;44:803-14. [DOI: 10.1111/1440-1681.12769] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
2 Bodmer D, Perkovic A, Sekulic-Jablanovic M, Wright MB, Petkovic V. Pasireotide prevents nuclear factor of activated T cells nuclear translocation and acts as a protective agent in aminoglycoside-induced auditory hair cell loss. J Neurochem 2016;139:1113-23. [PMID: 27787949 DOI: 10.1111/jnc.13880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 Rai U, Thrimawithana TR, Valery C, Young SA. Therapeutic uses of somatostatin and its analogues: Current view and potential applications. Pharmacol Ther 2015;152:98-110. [PMID: 25956467 DOI: 10.1016/j.pharmthera.2015.05.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 9.6] [Reference Citation Analysis]
4 Rossino MG, Dal Monte M, Casini G. Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy. Front Neurosci 2019;13:1172. [PMID: 31787868 DOI: 10.3389/fnins.2019.01172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
5 Cervia D, Catalani E, Casini G. Neuroprotective Peptides in Retinal Disease. J Clin Med 2019;8:E1146. [PMID: 31374938 DOI: 10.3390/jcm8081146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
6 Vogler S, Hollborn M, Berk BA, Pannicke T, Seeger J, Wiedemann P, Reichenbach A, Bringmann A. Ischemic regulation of brain-derived neurotrophic factor-mediated cell volume and TrkB expression in glial (Müller) and bipolar cells of the rat retina. Graefes Arch Clin Exp Ophthalmol 2016;254:497-503. [PMID: 26743749 DOI: 10.1007/s00417-015-3250-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Bisht R, Nirmal S, Agrawal R, Jain GK, Nirmal J. Injectable in-situ gel depot system for targeted delivery of biologics to the retina. J Drug Target 2021;29:46-59. [PMID: 32729731 DOI: 10.1080/1061186X.2020.1803886] [Reference Citation Analysis]
8 Vörös I, Sághy É, Pohóczky K, Makkos A, Onódi Z, Brenner GB, Baranyai T, Ágg B, Váradi B, Kemény Á, Leszek P, Görbe A, Varga ZV, Giricz Z, Schulz R, Helyes Z, Ferdinandy P. Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection. Front Pharmacol 2021;12:663655. [PMID: 34803662 DOI: 10.3389/fphar.2021.663655] [Reference Citation Analysis]
9 Martel G, Dutar P, Epelbaum J, Viollet C. Somatostatinergic systems: an update on brain functions in normal and pathological aging. Front Endocrinol (Lausanne) 2012;3:154. [PMID: 23230430 DOI: 10.3389/fendo.2012.00154] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
10 Perianes-cachero A, Canelles S, Aguado-llera D, Frago LM, Toledo-lobo MV, Carrera I, Cacabelos R, Chowen JA, Argente J, Arilla-ferreiro E, Barrios V. Reduction in Aβ-induced cell death in the hippocampus of 17β-estradiol-treated female rats is associated with an increase in IGF-I signaling and somatostatinergic tone. J Neurochem 2015;135:1257-71. [DOI: 10.1111/jnc.13381] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
11 D'Alessandro A, Cervia D, Catalani E, Gevi F, Zolla L, Casini G. Protective effects of the neuropeptides PACAP, substance P and the somatostatin analogue octreotide in retinal ischemia: a metabolomic analysis. Mol Biosyst 2014;10:1290-304. [PMID: 24514073 DOI: 10.1039/c3mb70362b] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
12 Hernández C, Simó-Servat O, Simó R. Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives. Endocrine 2014;46:209-14. [PMID: 24627166 DOI: 10.1007/s12020-014-0232-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
13 Akki R, Siracusa R, Cordaro M, Remigante A, Morabito R, Errami M, Marino A. Adaptation to oxidative stress at cellular and tissue level. Arch Physiol Biochem 2019;:1-11. [PMID: 31835914 DOI: 10.1080/13813455.2019.1702059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]